This topic contains a solution. Click here to go to the answer

Author Question: Which of the following was a prominent bebop pianist? a. Thelonious Monk b. Duke Ellington c. ... (Read 22 times)

magmichele12

  • Hero Member
  • *****
  • Posts: 559
Which of the following was a prominent bebop pianist?
 
  a. Thelonious Monk
  b. Duke Ellington
  c. Keith Jarrett
  d. Earl Hines

Question 2

After listening to the selection which statement best describes Mingus' arranging technique?
 
  a. A single melody played in unison
  b. A single melody with countermelodies moving underneath and around it
  c. Call and response between the horns
  d. Harmonized melody lines



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

sierramartinez

  • Sr. Member
  • ****
  • Posts: 313
Answer to Question 1

a

Answer to Question 2

b. A single melody with countermelodies moving underneath it



magmichele12

  • Hero Member
  • *****
  • Posts: 559
Both answers were spot on, thank you once again




 

Did you know?

Your chance of developing a kidney stone is 1 in 10. In recent years, approximately 3.7 million people in the United States were diagnosed with a kidney disease.

Did you know?

On average, the stomach produces 2 L of hydrochloric acid per day.

Did you know?

Approximately one in three babies in the United States is now delivered by cesarean section. The number of cesarean sections in the United States has risen 46% since 1996.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library